Distinguished U-M neuroscientist Huda Akil, Ph.D., has received the nation’s highest scientific honor – the National Medal of Science -- for her contributions to science and their impact on humankind’s understanding of depression, anxiety, addiction and more.

An interview with Dr. Jessica Anand on pharmacology, developing new opioid rescue therapies and diversity, equity and inclusion.

A promising target for new and improved antibiotics are riboswitches, small stretches of RNA that regulate a process necessary for the production of proteins by the bacterial cell.

A highly complicated experiment designed to reveal how SARS-CoV-2 causes infection by hijacking cellular machinery is published by a team of investigators at Michigan Medicine.

Russell Ryan, MD, and his team’s discovery appears to address longstanding mysteries about mutations found in B-cell acute lymphoblastic leukemia

Discovery research updates

An update on basic and translational research at Michigan Medicine

Discovery Research updates

Sulfur, B12, and Criminal Justice Reform

In this episode we talk with Dr. Ken Langa about the implications of identification of “preclinical” Alzheimer’s disease (situations where individuals may have biological signs of Alzheimer’s but no symptoms). Ken is a leading dementia researcher and our discussion focuses on an article he published called “Preclinical Alzheimer Disease – Early Diagnosis or Overdiagnosis” that was published in JAMA Internal Medicine. In his article co-authored with Dr. Jim Burke, he brings up some of the potential indirect effects of early detection.

Test your scientific knowledge of COVID-19 and the RNA vaccines.

Experts weigh in on the latest research at Michigan Medicine.

Meet interim executive vice dean Steven Kunkel

A selection of the significant breakthroughs in cancer research at U-M

Message from the new chief scientific officer